Avinger, Inc.

Visit us at booth #114 at ! Discover Tigereye ST - designed for predictable, durable outcomes and true lumen CTO-crossing success. With a powerful, steerable distal tip and onboard image guidance, you'll want to come demo it today!

Stop by booth #114 to check out Pantheris LV! This cutting-edge device combines directional atherectomy with real-time, onboard image guidance, ensuring safety, precision, and maximal luminal gain. Don’t miss out!

Discover Avinger's Lightbox 3 at in New Orleans! Our advanced system powers real-time, inside-the-vessel guidance, enabling safer, more effective vascular treatments. Visit booth #114 for a demo and see how we deliver impactful, long-term results.

From all of us at Avinger, we honor the dedication and heroism of our EMS professionals. Your tireless efforts save lives every day. Thank you for your unwavering commitment. Happy National EMS Week! 🚑❤️

🌟 Happy Nurses Week! 🌟 Honoring all nurses for your dedication and compassion. You are the heartbeat of healthcare. At Avinger, we celebrate your commitment to healing and patient care. You truly make the world better, one patient at a time.

🥇First-time use of Avinger’s Tigereye ST & Pantheris SV leads to remarkable success in a difficult ISR CTO case! Dr. Asfaw achieved excellent results without additional stenting. A true testament to innovation in patient care!

🌟 Welcome to the Avinger family! Our new Clinical Specialists, Territory Sales Managers, and Area Sales Directors are ready to advise your OCT-guided Lumivascular cases after their home office training! Reach out to meet them!

Thanks to all the skilled technicians who joined Avinger BEAM—our specialized Lumivascular OCT Imaging Training. Avinger BEAM is designed for experienced technicians to advance their skills and for new technicians keen to explore Lumivascular technology! Stay tuned for more BEAM events!

Dr. Marc Salhanick successfully crosses a 300mm De Novo SFA lesion with Avinger's Tigereye ST. Tigereye ST masterfully conquers fibrotic CTOs with cutting-edge precision. See the results and Avinger's OCT imaging impact firsthand!

Learn about Dr. Salhanick's practice today! – https://hubs.la/Q02sJvyc0

Which captivated you more today: the rare beauty of the natural solar eclipse or the striking clarity of Avinger's OCT imaging? Share your thoughts! 🌘🔭

Let's Sock it to PAD! Today is National Red Sock Day 🔴🧦, so join us in bringing awareness to Peripheral Artery Disease. PAD is responsible for nearly 200,000 amputations annually, more than half of which are preventable with early diagnosis and treatment. Get your guide to PAD and learn about restoring blood flow today.

Peripheral Artery Disease Patient Guide Restoring Flow Down to the Toes Download guide to Peripheral Artery Disease symptoms and treatment. PAD affects your legs and feet.

🌟 New Year, New You! Transform your health with our blog on Exercise Therapy for PAD. Discover its benefits, ideal exercises, and more for a healthier 2024. Start your journey to vitality today! 🏃‍♂️💪 https://hubs.la/Q02jp5SS0

We are so pleased that Avinger's Lumivascular technology was highlighted this year at The Amputation Prevention Symposium (AMP) by key opinion leaders in the fields of vascular intervention:

• Dr. Thomas Davis, an interventional cardiologist, and the Director of the Cardiac Catheterization Lab, and Peripheral Interventions at St. John Hospital and Medical Center in Detroit, featured Avinger's Pantheris SV (small vessel) OCT-guided atherectomy system in his sessions, "Late Breaking: OCT-Guided Atherectomy of Lesions BTK: Real-Time Imaging That Provides Real-World Data," and "New Insights on the Anatomy of BTK Lesions Based on Intravascular Imaging."

•Dr. Ian Cawich, a coronary, peripheral, and vascular interventionalist and limb salvage expert at Arkansas Heart in Little Rock, highlighted Avinger's proprietary OCT-guided atherectomy technologies in his session, "How to Use OCT Imaging in CLI: Tips and Tricks."

AMP focuses on education and technologies for treating critical limb ischemia, an advanced stage of PAD, in patients facing a life-altering amputation. The conference features lectures by internationally recognized faculty, live case symposia, hands-on workshops, and exhibits supporting the mission of amputation prevention.

#2023

This past year, we took pride in the fact that two respected thought leaders in interventional cardiology and endovascular interventions delivered speeches at the Leipzig Interventional Course (LINC) on Avinger's Lumivascular technology. LINC is a leading global forum for new methods and technology in the field of vascular medicine held each year in Leipzig, Germany.

• Dr. Arne Schwindt, a vascular surgeon at St. Franziskus Hospital in Münster, Germany and a pioneer in the OCT-guided treatment of vascular disease, featured Avinger's Pantheris OCT-guided atherectomy system and the results of the INSIGHT trial in his presentation, "Gender Differences in Treatment of ISR Lesions with the Pantheris Atherectomy Catheter." The INSIGHT trial was designed to evaluate the safety and effectiveness of Avinger's Pantheris image-guided atherectomy system for treating in-stent restenosis (ISR) in lower extremity arteries.

• Dr. Michael Lichtenberg, Chief Medical Officer and Director of the Angiology Department and Vascular Center at Klinikum Arnsberg, presented interim data from the post-market IMAGE-BTK trial designed to evaluate the safety and effectiveness of Avinger's Pantheris SV OCT-guided atherectomy system in treating below-the-knee lesions. His presentation was entitled, "Treatment of Stenotic Lesions Below-the-Knee with an OCT-Guided Atherectomy Catheter."

On behalf of everyone at Avinger, we send you heartfelt greetings for a delightful and memorable Holiday season! May this time bring you boundless joy, wonderful memories, and an abundance of laughter among family and friends. Happy Holidays!

This past year we were proud that two esteemed opinion leaders in the fields of interventional cardiology and endovascular interventions spoke at the New Cardiovascular Horizons Annual Conference in the following sessions on Avinger's Lumivascular technology:

▪️Dr. Ian Cawich, a distinguished interventional cardiologist hailing from Arkansas Heart in Little Rock, took center stage to shine a spotlight on Avinger's entire portfolio of proprietary OCT-guided atherectomy technologies. His session, aptly titled "OCT-Guided Atherectomy of ATK and BTK Lesions," illuminated the groundbreaking advancements made in this field.

▪️Dr. Jon George, Director of Complex Interventions and a renowned interventional cardiologist and endovascular medicine specialist at Pennsylvania Hospital within the University of Pennsylvania Health System, graced us with his expertise. He featured Avinger's Pantheris SV (small vessel) OCT-guided atherectomy system in his session, titled "Utility of the Pantheris Atherectomy Device with OCT Imaging in Treating BTK Lesions." Dr. George also shared the latest insights from the ongoing IMAGE-BTK clinical study, providing invaluable updates to our collective knowledge.

#2023

As we reflect on the year 2023, we proudly mark one of Avinger's standout accomplishments: the FDA's granting of 510(k) Clearance for Pantheris LV, an innovative image-guided atherectomy system designed to excel in the treatment of larger blood vessels.

Pantheris LV is designed for treatment in larger vessels, such as the SFA and popliteal arteries, where the majority of PAD procedures are performed today. Pantheris LV offers multiple new features and benefits to physician users, including higher cutter speeds for more efficient removal of challenging occlusive tissue and a proprietary design for plaque apposition to improve procedural efficiency. Pantheris LV incorporates several additional features to streamline and simplify user-operation, including design improvements for enhanced torque feedback, guidewire management, and improved tissue packing and removal.

#2023

One of our proudest accomplishments of the year was on June 5th, 2023 when we announced the successful completion of the first clinical cases with the new Tigereye ST image-guided CTO crossing system.

Tigereye ST incorporates design upgrades to the tip configuration and catheter shaft to increase crossing power and procedural success in challenging lesions, as well as design enhancements for ease of image interpretation during the procedure. Product specifications include a working length of 140 cm, 5 French sheath compatibility, and low crossing profile for treatment of lesions in the peripheral vessels both above and below the knee.

We're thrilled to share a standout moment of 2023: unveiling clinical findings from the INSIGHT study at the prestigious Charing Cross (CX) International Symposium in London, UK.

The CX Symposium, a premier event in vascular and endovascular education, is all about pushing boundaries in education, innovation, and evidence. The INSIGHT trial has been a pivotal journey, exploring the safety and efficacy of Avinger's Pantheris image-guided atherectomy system in tackling in-stent restenosis (ISR) in lower extremity arteries.

Looking back on 2023, we proudly celebrate one of Avinger's most significant accomplishments of the year: the successful attainment of 510(k) Clearance for our Tigereye ST Image-Guided CTO Crossing System. This milestone underscores our unwavering commitment to innovation and the advancement of medical solutions. We extend our gratitude to the dedicated team and all contributors who played a pivotal role in this success. Here's to a year filled with remarkable achievements and looking forward to continued excellence in the future!

#2023

As we reflect on 2023, we celebrate that on January 11, 2023, Avinger proudly submitted a 510(k) application to the U.S. Food & Drug Administration (FDA) for Pantheris LV—an innovative image-guided atherectomy system designed for treating larger vessels.

Reflecting on the journey, we appreciate the support from our dedicated team and everyone who contributed to this milestone. Here's to a year of progress, innovation, and a continued commitment to advancing healthcare!

December marks the culmination of a year's journey for Avinger. As we reflect on the past 12 months, we celebrate our commitment to patient-centric care, operational excellence, and innovation. It's a time to appreciate our milestones and aspire to change how vascular disease is treated.

November is Diabetes Awareness Month! Let's shed light on a critical issue: Nearly half (44.7%) of adults with diabetes (239.7M) were unaware of their status. Early diagnosis is crucial. Let's raise awareness and support those affected!

Sending gratitude from the entire Avinger team! Thank you for your ongoing support, and we wish you a wonderful Thanksgiving celebration!

During Diabetes Awareness Month, highlighting the urgency of early intervention in combating complications linked to diabetes is crucial. Understanding the challenges is key to fostering awareness and support. FightAgainstDiabetes

November is Diabetes Awareness Month! Did you know that diabetes affects over 170 million people worldwide today, with an anticipated rise to 366 million by 2030? This month, let's focus on understanding the challenges faced by those with diabetes, including complications like foot ulcers and amputations.

Millions of lives are impacted each year, making awareness crucial. Explore more about this pressing issue and discover ways to support the cause in our blog post. Knowledge is key!

Explore the Blog Here: Diabetes - The Problem of Plaque and Peripheral Artery Disease: https://hubs.la/Q0299yXy0

Enormous gratitude to Dr. Todd Vogel for highlighting Avinger’s Lumivascular technology with his presentation at titled: “Update On Optical Coherence Tomography (OCT) Guided Intraluminal Crossing Catheters (Avinger) For SFA Occlusions: Intraluminal Patency Superiority And New Data On The TigerEye Catheter”

Dr. Vogel, Professor of Surgery and Vice-Chair of Health Services Research at the University of Missouri-Columbia, is at the forefront of innovation in the field. As the Chief of Vascular Surgery at the University of Missouri Health - Heart & Vascular Center, his insights are invaluable.

November is Diabetes Awareness Month! 85% of diabetes-related amputations follow a foot ulcer. Early detection is key. Let's spread awareness, encourage regular check-ups, and support each other on the journey to better diabetes management. 💙🩸

November is Diabetes Awareness Month! Women face more challenges but may get less treatment. Curious to learn more? Click here: https://hubs.la/Q028pcmH0 Let's raise awareness, support, and share knowledge this month!

Women More Affected Than Men by Vascular Complications of Diabetes In women, the links between diabetes and Peripheral Artery Disease are particularly potent.

This Diabetes Awareness Month, witness the life-changing impact of Lumivascular technology in preventing limb loss.. Find a Lumivascular doctor near you and take control of your vascular health: https://hubs.la/Q027V_KG0